Eupraxia Pharmaceuticals (EPRX) Institutional Ownership $5.30 -0.10 (-1.78%) Closing price 08/1/2025 03:50 PM EasternExtended Trading$5.58 +0.27 (+5.18%) As of 08/1/2025 05:16 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Ownership Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesOwnershipSEC FilingsShort InterestTrendsBuy This Stock Institutional Ownership Changes (13F Filings) for Eupraxia Pharmaceuticals (NASDAQ:EPRX)Number ofInstitutional Buyers(last 12 months)6TotalInstitutional Inflows(last 12 months)$1.07MNumber ofInstitutional Sellers(last 12 months)1TotalInstitutional Outflows(last 12 months)$14.46K Get EPRX Insider Trade Alerts Want to know when executives and insiders are buying or selling Eupraxia Pharmaceuticals stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data EPRX Institutional Buying and Selling by Quarter Eupraxia Pharmaceuticals Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails7/31/2025 Ingalls & Snyder LLC37,200$214K0.0%N/A0.103% 5/15/2025Royal Bank of Canada342,828$1.13M0.0%+21.1%0.956% 5/9/2025Scotia Capital Inc.1,552,679$5.07M0.0%+11.6%4.331% 2/17/2025Millennium Management LLC10,000$31K0.0%N/A0.028% 2/13/2025Scotia Capital Inc.1,391,719$4.26M0.0%-0.3%3.907% 2/13/2025Raymond James Financial Inc.11,613$37K0.0%N/A0.033% 2/13/2025Bank of Montreal Can56,750$178K0.0%+15.2%0.159% 2/6/2025Raymond James Financial Inc.11,613$37K0.0%N/A0.033% 7/17/2024 180 Wealth Advisors LLC13,000$34K0.0%N/A0.048% (Data available from 1/1/2016 forward) EPRX Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of EPRX shares? During the previous two years, the following institutional investors and hedge funds held shares of Eupraxia Pharmaceuticals shares: Scotia Capital Inc. ($5.07M), Royal Bank of Canada ($1.13M), Ingalls & Snyder LLC ($214K), Bank of Montreal Can ($178K), Raymond James Financial Inc. ($37K), and 180 Wealth Advisors LLC ($34K), and Millennium Management LLC ($31K).Learn more on Eupraxia Pharmaceuticals' institutional investors. Which institutional investors have been buying Eupraxia Pharmaceuticals' stock? The following institutional investors have purchased Eupraxia Pharmaceuticals' stock in the last 24 months: Scotia Capital Inc. ($160.96K), Royal Bank of Canada ($59.68K), Ingalls & Snyder LLC ($37.20K), Raymond James Financial Inc. ($23.23K), 180 Wealth Advisors LLC ($13K), Millennium Management LLC ($10K), and Bank of Montreal Can ($7.50K). How much institutional buying is happening at Eupraxia Pharmaceuticals? Institutional investors have bought a total of 298,569 shares in the last 24 months. This purchase volume represents approximately $1.07M in transactions. Which of Eupraxia Pharmaceuticals' major shareholders have been selling company stock? The following institutional investors have sold Eupraxia Pharmaceuticals stock in the last 24 months: Scotia Capital Inc. ($4.56K). How much institutional selling is happening at Eupraxia Pharmaceuticals? Institutional investors have sold a total of 4,562 shares in the last 24 months. This volume of shares sold represents approximately $14.46K in transactions. Related Companies Amylyx Pharmaceuticals Institutional Ownership Xencor Institutional Ownership Autolus Therapeutics Institutional Ownership atai Life Sciences Institutional Ownership Dianthus Therapeutics Institutional Ownership Day One Biopharmaceuticals Institutional Ownership Pharming Group Institutional Ownership Gyre Therapeutics Institutional Ownership MeiraGTx Institutional Ownership Prime Medicine Institutional Ownership This page (NASDAQ:EPRX) was last updated on 8/2/2025 by MarketBeat.com Staff From Our PartnersBuffett to put 90% of his money in this one stock?CPA and CFA says you have WAY too many stocks - just buy these 3 After years working at the biggest accoun...Altimetry | SponsoredHe Called Nvidia at $1.10. Now, He Says THIS Stock Will…The original Magnificent Seven returned 16,894%—turning $7K into $1.18 million. Now, the man who called Nvi...The Oxford Club | SponsoredOne stock to replace NvidiaI'm a Futurist: Here are 3 stocks better than Nvidia Nvidia's own customers could soon become fierce compet...InvestorPlace | SponsoredJeff Bezos Launches "ChatGPT Killer"?Amazon just launched Nova—its secretive new AI system designed to rival ChatGPT. Bezos says he now spends 95% ...Stansberry Research | SponsoredAlien rocks potentially worth trillions…It might look like just a weird rock—but it’s tied to a discovery 60 Minutes says could be worth up to $16 tri...Porter & Company | SponsoredTrump’s crypto advisor may have revealed the next big crypto opportunityWhile investors chase Bitcoin toward $100K, D.C. insiders are quietly loading up on something else. One of Tru...Weiss Ratings | Sponsored[No Brainer Gold Play]: “Show me a better investment.”A Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the...Golden Portfolio | SponsoredToo busy to trade? Good.Too busy to trade? That might be your edge. This after-hours strategy is built for people who don’t sit at ...Timothy Sykes | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Eupraxia Pharmaceuticals Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Eupraxia Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free EPRX Stock Alerts